PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 31 filers reported holding PHARMACYTE BIOTECH INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,383 | -75.6% | 92,087 | -66.8% | 1.31% | -73.5% |
| Q2 2023 | $792,197 | -73.6% | 276,992 | -73.1% | 4.95% | -54.1% |
| Q1 2023 | $2,998,842 | -0.9% | 1,030,530 | -0.3% | 10.77% | +30.2% |
| Q4 2022 | $3,027,071 | +22.1% | 1,033,130 | 0.0% | 8.27% | +90.0% |
| Q3 2022 | $2,480,000 | +623.0% | 1,033,130 | +574.7% | 4.35% | +681.1% |
| Q2 2022 | $343,000 | -2.6% | 153,130 | 0.0% | 0.56% | +21.9% |
| Q1 2022 | $352,000 | -8.1% | 153,130 | 0.0% | 0.46% | +26.6% |
| Q4 2021 | $383,000 | – | 153,130 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|